# GALT (Galectin Therapeutics Inc.) - SEC EDGAR Financial Statements

> Galectin Therapeutics Inc. reported $13.01M in total assets and a net loss of $23.19M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/GALT
- Markdown: https://convexityos.com/fundamentals/GALT.md
- SEC CIK: 0001133416
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:43 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001133416&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$14.79M | Operating profit |
| Net Income | FY 2025 | -$23.19M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.26 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $11.71M | Total debt: $104K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $14.29M | $36.57M | $32.13M | $31.74M | $23.82M | $17.98M | $7.47M | $6.47M | $11.72M | $15.32M |
| Total Operating Expenses | $20.09M | $42.43M | $38.07M | $38.35M | $30.18M | $23.44M | $13.44M | $13.60M | $16.25M | $21.48M |
| **Operating Income** | -$20.09M | -$42.43M | -$38.07M | -$38.35M | -$30.18M | -$23.44M | -$13.44M | -$13.60M | -$16.25M | -$21.48M |
| **EBITDA** | -- | -$42.43M | -$38.07M | -$38.35M | -$30.18M | -$23.44M | -$13.44M | -$13.60M | -$16.25M | -$21.47M |
| Interest Income | $126K | $338K | $230K | $52K | $3.0K | $66K | $231K | $38K | $24K | $45K |
| Interest Expense | $7.33M | $5.54M | $2.79M | $1.03M | $489K | $87K | $87K | $336K | $12K | -- |
| Income Tax Expense | $0 | $0 | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$30.84M | -$47.05M | -$41.07M | -$38.78M | -$30.53M | -$23.46M | -$13.29M | -$13.90M | -$16.23M | -$21.44M |
| Basic EPS | -$0.48 | -$0.76 | -$0.74 | -$0.65 | -$0.52 | -$0.41 | -$0.39 | -$0.38 | -$0.49 | -$0.76 |
| **Diluted EPS** | -$0.48 | -$0.76 | -$0.74 | -$0.65 | -$0.52 | -$0.41 | -$0.39 | -$0.38 | -$0.49 | -$0.76 |
| Basic Shares Outstanding | 63.9M | 62.3M | 60.2M | 59.4M | 58.5M | 57.0M | 52.2M | 39.4M | 35.5M | 29.2M |
| Diluted Shares Outstanding | 63.9M | 62.3M | 60.2M | 59.4M | 58.5M | 57.0M | 52.2M | 39.4M | 35.5M | 29.2M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.56M | $2.13M | $2.23M | $1.93M | $2.61M | $3.26M | $6.49M | $11.11M |
| Total Operating Expenses | $3.37M | $3.98M | $4.08M | $3.37M | $4.20M | $4.62M | $7.90M | $12.43M |
| **Operating Income** | -$3.37M | -$3.98M | -$4.08M | -$3.37M | -$4.20M | -$4.62M | -$7.90M | -$12.43M |
| Interest Income | $28K | $28K | $36K | $25K | $39K | $26K | $35K | $84K |
| Interest Expense | $786K | $2.00M | $1.99M | $1.94M | $1.82M | $1.83M | $1.74M | $1.73M |
| **Net Income** | -$3.53M | -$9.11M | -$5.05M | -$5.50M | -$8.18M | -$7.52M | -$9.63M | -$11.97M |
| Basic EPS | -$0.04 | -$0.14 | -$0.08 | -- | -$0.13 | -$0.12 | -$0.15 | -- |
| **Diluted EPS** | -$0.04 | -$0.14 | -$0.08 | -- | -$0.13 | -$0.12 | -$0.15 | -- |
| Basic Shares Outstanding | 89.6M | 65.9M | 65.8M | -- | 64.2M | 63.4M | 63.2M | -- |
| Diluted Shares Outstanding | 89.6M | 65.9M | 65.8M | -- | 64.2M | 63.4M | 63.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $17.72M | $15.12M | $25.66M | $18.59M | $39.65M | $27.14M | $47.48M | $8.25M | $3.05M | $15.36M |
| **Cash & Short-Term Investments** | $17.72M | $15.12M | $25.66M | $18.59M | $39.65M | $27.14M | $47.48M | $8.25M | $3.05M | $15.36M |
| **Total Current Assets** | $19.44M | $17.25M | $27.71M | $20.55M | $41.82M | $29.46M | $48.21M | $8.83M | $3.82M | $15.79M |
| Property, Plant & Equipment, Net | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | -- | -- | -- | -- | -- | -- | -- | $0 | $0 | $1.0K |
| Other Non-Current Assets | $96K | $243K | $490K | $733K | $7.0K | $135K | $258K | $174K | $342K | -- |
| **Total Non-Current Assets** | $96K | $243K | $490K | $733K | $7.0K | $135K | $258K | $174K | $342K | $1.0K |
| **Total Assets** | $19.53M | $17.50M | $28.20M | $21.29M | $41.83M | $29.60M | $48.47M | $9.01M | $4.16M | $15.79M |
| Accounts Payable | $3.25M | $5.66M | $6.43M | $3.89M | $1.80M | $1.29M | $1.66M | $297K | $608K | $910K |
| **Total Current Liabilities** | $8.03M | $35.41M | $15.68M | $13.01M | $9.03M | $5.40M | $2.82M | $2.11M | $2.97M | $3.78M |
| Other Non-Current Liabilities | $0 | $0 | $20K | $66K | $0 | $8.0K | $52K | $0 | -- | -- |
| **Total Non-Current Liabilities** | $137.7M | $85.16M | $72.77M | $40.47M | $30.18M | $8.0K | $52K | $0 | $0 | $0 |
| **Total Liabilities** | $145.7M | $120.6M | $88.44M | $53.48M | $39.21M | $5.41M | $2.87M | $2.11M | $2.97M | $3.78M |
| **Total Debt (incl. Leases)** | $22K | $19K | $66K | $106K | $8.0K | $52K | $90K | -- | -- | -- |
| Common Stock | $65K | $62K | $61K | $59K | $59K | $56K | $56K | $41K | $36K | $33K |
| Retained Earnings | -$432.5M | -$401.6M | -$354.4M | -$309.6M | -$270.7M | -$240.0M | -$216.4M | -$196.2M | -$181.2M | -$163.7M |
| **Total Stockholders' Equity** | -$127.9M | -$104.8M | -$61.96M | -$33.92M | $893K | $22.47M | $43.87M | $5.17M | -$530K | $10.29M |
| Total Equity | -$127.9M | -$104.8M | -$61.96M | -$33.92M | $893K | $22.47M | $43.87M | $5.17M | -$530K | $10.29M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $11.71M | $13.27M | $14.11M | $17.72M | $11.53M | $13.77M | $7.43M | $15.12M |
| **Cash & Short-Term Investments** | $11.71M | $13.27M | $14.11M | $17.72M | $11.53M | $13.77M | $7.43M | $15.12M |
| **Total Current Assets** | $12.90M | $14.66M | $15.69M | $19.44M | $12.73M | $15.43M | $9.29M | $17.25M |
| Property, Plant & Equipment, Net | -- | -- | -- | $0 | -- | -- | -- | $0 |
| Other Non-Current Assets | $104K | $167K | $68K | $96K | $136K | $175K | $243K | $243K |
| **Total Non-Current Assets** | $104K | $167K | $68K | $96K | $136K | $175K | $243K | $243K |
| **Total Assets** | $13.01M | $14.83M | $15.76M | $19.53M | $12.87M | $15.60M | $9.53M | $17.50M |
| Accounts Payable | $3.50M | $3.73M | $3.12M | $3.25M | $5.39M | $5.87M | $6.53M | $5.66M |
| **Total Current Liabilities** | $46.41M | $151.6M | $7.31M | $8.03M | $136.4M | $10.77M | $110.8M | $35.41M |
| Other Non-Current Liabilities | $42K | $59K | -- | $0 | -- | -- | -- | $0 |
| **Total Non-Current Liabilities** | $42K | $59K | $138.7M | $137.7M | $0 | $122.0M | $10.95M | $85.16M |
| **Total Liabilities** | $46.45M | $151.7M | $146.0M | $145.7M | $136.4M | $132.8M | $121.8M | $120.6M |
| **Total Debt (incl. Leases)** | $104K | $118K | $6.0K | $22K | $37K | $52K | $68K | $19K |
| Common Stock | $100K | $66K | $65K | $65K | $64K | $63K | $63K | $62K |
| Retained Earnings | -$450.4M | -$446.8M | -$437.6M | -$432.5M | -$427.0M | -$418.8M | -$411.2M | -$401.6M |
| **Total Stockholders' Equity** | -$35.16M | -$139K | -$132.0M | -$127.9M | -$125.3M | -$118.9M | -$114.0M | -$104.8M |
| Total Equity | -$35.16M | -$139K | -$132.0M | -$127.9M | -$125.3M | -$118.9M | -$114.0M | -$104.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$30.84M | -$47.05M | -$41.07M | -$38.78M | -$30.53M | -$23.46M | -$13.29M | -$13.90M | -$16.23M | -$21.44M |
| Depreciation & Amortization | -- | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $1.0K | $7.0K |
| Stock-Based Compensation | $1.66M | $2.45M | $2.26M | $2.87M | $2.08M | $1.80M | $1.68M | $4.45M | $1.10M | $2.48M |
| **Operating Cash Flow** | -$23.88M | -$41.77M | -$32.97M | -$31.06M | -$24.31M | -$20.60M | -$10.85M | -$10.18M | -$15.89M | -$16.41M |
| **Investing Cash Flow** | $0 | $0 | $0 | $0 | $0 | $0 | -- | $0 | $0 | $0 |
| Common Stock Issued | $3.23M | $0 | -- | $0 | $6.81M | $263K | $50.47M | $15.38M | $3.58M | $5.92M |
| **Financing Cash Flow** | $26.48M | $31.23M | $40.03M | $10.00M | $36.81M | $263K | $50.08M | $15.38M | $3.58M | $5.92M |
| **Net Change in Cash** | $2.60M | -$10.54M | $7.07M | -$21.06M | $12.51M | -$20.34M | $39.23M | $5.20M | -$12.31M | -$10.48M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.53M | -$9.11M | -$5.05M | -$5.50M | -$8.18M | -$7.52M | -$9.63M | -$11.97M |
| Stock-Based Compensation | $949K | $963K | $686K | $195K | $496K | $500K | $468K | $590K |
| **Operating Cash Flow** | -$2.27M | -$2.44M | -$3.87M | -$6.04M | -$3.54M | -$6.60M | -$7.69M | -$12.79M |
| **Financing Cash Flow** | $702K | $1.60M | $257K | $12.24M | $1.30M | $12.94M | $0 | $851K |
| **Net Change in Cash** | -$1.56M | -$842K | -$3.61M | $6.20M | -$2.25M | $6.34M | -$7.69M | -$11.94M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -- | -3418.5% | -104.4% | -30.3% | -268.6% | -- | -208.3% |
| Return on Assets (ROA) | -157.9% | -268.9% | -145.6% | -182.2% | -73.0% | -79.3% | -27.4% | -154.3% | -390.2% | -135.7% |
| Current Ratio | 2.42x | 0.49x | 1.77x | 1.58x | 4.63x | 5.46x | 17.10x | 4.19x | 1.29x | 4.18x |
| Quick Ratio | 2.21x | 0.43x | 1.64x | 1.43x | 4.39x | 5.03x | 16.84x | 3.92x | 1.03x | 4.06x |
| Debt to Equity | -- | -- | -- | -- | 0.01x | 0.00x | 0.00x | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -178.3% | -187.8% | -166.6% | -157.9% | -290.0% | -258.6% | -474.3% | -268.9% |
| Current Ratio | 0.28x | 0.10x | 2.15x | 2.42x | 0.09x | 1.43x | 0.08x | 0.49x |
| Quick Ratio | 0.25x | 0.09x | 1.93x | 2.21x | 0.08x | 1.28x | 0.07x | 0.43x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
